>According to the National Institute of Health (NIH), Delta-8-THC binds to the CB1 receptors located in the central nervous system. Delta-8-THC additionally has an affinity for CB2 receptors, although less is known about this binding mechanism.
Delta-8-THC contains a bond on the 8th carbon chain and is studied as having a noticeable effect on how the body’s endocannabinoid receptors bind and respond to the molecule.
In addition, delta-8-THC is stable, does not oxidize to become cannabinol, and boasts a prolonged shelf life. Such stability is very desirable in a medicinal compound.